Volume 111, Nº 2, August 2018
DOI: http://www.dx.doi.org/10.5935/abc.20180147
SHORT EDITORIAL
VEGFR-2: One of Pioglitazone’s Signaling Pathways in the Heart
Marcos Ferreira Minicucci
Leonardo Antonio Mamede Zornoff
Keywords: Peroxisome Proliferators/adverse effects; Glucose/ metabolism; Lipids/metabolism; Pioglitazone, Diabetes Mellitus/drug therapy.